Abstract:The binding stoichiometry between Cu(II) and the full-length beta-amyloid A beta(l -42) and the oxidation state of copper in the resultant complex were determined by electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) and cyclic voltammetry. The same approach was extended to the copper complexes of A beta(1-16) and A beta(1-28). A stoichiometric ratio of 1:1 was directly observed, and the oxidation state of copper was deduced to be 2+ for all of the complexes, and residues tyrosine-10 and methionine-35 are not oxidized in the A beta(1-42)-Cu(II) complex. The stoichiometric ratio remains the same in the presence of more than a 10-fold excess of Cu(II). Redox potentials of the sole tyrosine residue and the Cu(II) center were determined to be ca. 0.75 and 0.08 V vs Ag/AgCl [or 0.95 and 0.28 V vs normal hydrogen electrode (NHE)], respectively. More importantly, for the first time, the A beta-Cu(I) complex has been generated electrochemically and was found to catalyze the reduction of oxygen to produce hydrogen peroxide. The voltammetric behaviors of the three A beta segments suggest that diffusion of oxygen to the metal center can be affected by the length and hydrophobicity of the A beta peptide. The determination and assignment of the redox potentials clarify some misconceptions in the redox reactions involving A beta and provide new insight into the possible roles of redox metal ions in the Alzheimer's disease (AD) pathogenesis. In cellular environments, the reduction potential of the A beta-Cu(II) complex is sufficiently high to react with antioxidants (e.g., ascorbic acid) and cellular redox buffers (e.g., glutathione), and the A beta-Cu(I) complex produced could subsequently reduce oxygen to form hydrogen peroxide via a catalytic cycle. Using voltammetry, the A beta-Cu(II) complex formed in solution was found to be readily reduced by ascorbic acid. Hydrogen peroxide produced, in addition to its role in damaging DNA, protein, and lipid molecules, can also be involved in the further consumption of antioxidants, causing their depletion in neurons and eventually damaging the neuronal defense system. Another possibility is that A beta-Cu(II) could react with species involved in the cascade of electron transfer events of mitochondria and might potentially sidetrack the electron transfer processes in the respiratory chain, leading to mitochondrial dysfunction.

The mechanism for heme to prevent Aβ 1–40 aggregation and its cytotoxicity

Heme-Aβ in SDS micellar environment: Active site environment and reactivity

Aβ interacts with both the iron center and the porphyrin ring of heme: mechanism of heme's action on Aβ aggregation and disaggregation.

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure

Amyloid-β-Heme Complex and Protein Tyrosine Nitration: Implications in Alzheimer's Desease

Molecular crowding effects on the biochemical properties of amyloid β–heme, Aβ–Cu and Aβ–heme–Cu complexes

Molecular crowding effects on the biochemical properties of amyloid -heme, A-Cu and A-heme-Cu complexes

Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A Against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons

Dual Functions of Beta-Amyloid Oligomer and Fibril in Cu(Ii)-Induced H2o2 Production

Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance<sup>†</sup>

Modulation Effect of Acidulated Human Serum Albumin on Cu2+-mediated Amyloid Β-Protein Aggregation and Cytotoxicity under a Mildly Acidic Condition.

Redox Reactions Of Copper Complexes Formed With Different Beta-Amyloid Peptides And Their Neuropathalogical Relevance

The Double-Edged Role of Copper in the Fate of Amyloid Beta in the Presence of Anti-Oxidants.

Nitration of Amyloid-Β Peptide (1–42) As a Protective Mechanism for the Amyloid-Β Peptide (1–42) Against Copper Ion Toxicity

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity

Serum albumin-embedding copper nanoclusters inhibit Alzheimer's β-amyloid fibrillogenesis and neuroinflammation

Molecular Modeling of the Inhibitory Mechanism of Copper(ii) on Aggregation of Amyloid Β-Peptide

Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A